Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage ...
RedEffect Official on MSN
Armata engine development controversy reflects uncertainty around T-14 program
The engine designed for Russia’s T-14 Armata tank has faced delays, redesigns, and conflicting reports about performance. Development challenges highlight how propulsion systems remain one of the most ...
The Armata is a new-generation tank. It is a clean sheet design with a number of advanced features. It has little in common with the current T-90 and other older Soviet tanks. Actually it it the first ...
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It ...
For more than a year and a half, heavy sanctions imposed by the U.S. and its North Atlantic Treaty Organization (NATO) allies have unquestionably hit Russia’s defense sector. Without the materials and ...
Armata Pharmaceuticals has posted early validation of its phage platform. The phase 1b/2a trial linked a bacteriophage cocktail to improved outcomes in patients with bacteria in their blood, opening ...
Summary: The T-14 Armata tank, unveiled in 2015, was intended to be a revolutionary advancement in armored warfare. -Featuring an unmanned turret, advanced armor, and a new 125mm smoothbore cannon, it ...
"The completion of enrollment of our diSArm study is a significant milestone in the development of AP-SA02, moving us one step closer to introducing an effective new treatment option to patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results